Translational Development Acquisition Corp. (TDAC) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

—

Levered DCF

—

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

20.44

Safe zone

Rating

A-

Overall 4 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022
P/E	28.35×	-617.9×	-392.55×	-575.29×
P/B	1.03×	0.26×	-375.63×	-1,833.75×
P/S	0×	0×	0×	0×
EV / EBITDA	-191.76×	-221.69×	-393.44×	0×
Gross margin	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	0.0%	0.0%	0.0%
Net margin	0.0%	0.0%	0.0%	0.0%
Current ratio	0.07×	3.09×	0×	0.12×
Debt / equity	0×	0×	-0.68×	-11.72×
Interest coverage	0×	0×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022
Return on equity	3.6%	-0.0%	95.6%	319.6%
Return on invested capital	-0.5%	-0.1%	303.2%	-29.8%
Return on assets	3.5%	-0.0%	-24025.2%	-16.2%
Free cash flow yield	-0.3%	-1.9%	-0.0%	-0.2%
Earnings yield	3.5%	-0.2%	-0.3%	-0.2%
Enterprise value	$181.1M	$43.5M	$191M	$40.8M
Net debt / EBITDA	-0.18×	2.23×	-0.71×	0×
Cash conversion cycle (days)	0	0	0	0